Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: Cheesehead who wrote (45102)	4/28/2000 10:03:00 AM
From: Cheesehead	Respond to of 150070

KAHI NEWS!! Sounds good! LOS ANGELES--(BUSINESS WIRE)--April 28, 2000-- Gross Revenues From the Limited Rollout of This Program Are Projected to Reach $250,000 Per Month by Q4 2000 Kaire Holdings Inc. (OTCBB:KAHI), an emerging developer of pure play Internet initiatives, today announced the unveiling of its Consumer Advocate Program (CAP), a program specifically designed to serve the needs of Spanish-speaking persons living with HIV or Acquired Immune Deficiency Syndrome (AIDS). Kaire Chairman and Chief Executive Officer Steven Westlund stated: "For the past five months, instead of throwing worlds of cash at various online and offline advertising campaigns (that produce minimal revenue returns), the YesRx Team was busy at work developing the YesRx Consumer Advocate Program (CAP). The CAP is the basic model that YesRx will use to grow its core businesses. We are confident that this program will not only significantly affect our respective top and bottom lines, but the program will also dramatically enhance the lives of the niche communities we are committed to serving." Westlund also stated: "Thus far, the YesRx HIV/AIDS Consumer Advocate Program (CAP) has been extremely well received in the Southern California Hispanic HIV/AIDS community. The need for our program is evident given the recent Government Accounting Office audit which found that `... compared with whites, African Americans and Hispanics receive less appropriate care for their HIV disease.' The GAO study took into account doctors' visits, emergency room visits, hospitalization and drug therapies. We are confident that the YesRx CAP will make a tremendous difference in these individuals' lives. "The YesRx CAP has four key elements: 1. We intend to dramatically improve drug compliance for patients where drug compliance is critical to the patient's overall state of health; 2. We will monitor and track the patient's progress and responses to various drug regimens; 3. We aim to enhance communication between the patient and physician; and lastly 4. Our program tracks medication supply to ensure the patient has access to life-sustaining medications. "The important thing to remember is that our revenue projections are for the Hispanic HIV/AIDS CAP for parts of Southern California. With this in mind, our revenue projections for this limited rollout barely scratch the surface of the potential Southern California market, much less the potential of a more robust national program. By the end of the year, it is our intention to broaden the scope of the HIV/AIDS CAP beyond the Spanish-speaking community, and to expand the geographical scope of the program beyond Southern California. Of course, while we are expanding the reach of the HIV/AIDS CAP, the YesRx Team has been directed to build additional CAPs for other disease states, and for various other focused chronic care populations." The company added: "The YesRx Team will be presenting the Hispanic HIV/AIDS CAP publicly for the first time at the 7th Annual Latino HIV/AIDS Conference 2000. The conference will be held at the Los Angeles Convention Center from June 10-12, 2000."